Funding vaccines for emerging infectious diseases-Reference-Cited by-同舟云学术

Funding vaccines for emerging infectious diseases

Published:2018-01-16 Issue:7 Volume:14 Page:1760-1762
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Wong Gary¹,Qiu Xiangguo²³

Affiliation:

1. Guangdong Key Laboratory for Diagnosis and Treatment of Emerging Infectious Diseases, Shenzhen Key Laboratory of Pathogen and Immunity, Shenzhen Third People's Hospital, Shenzhen, China

2. Special Pathogens Program, National Microbiology Laboratory, Winnipeg, Canada

3. Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada

Funder

National Key Research and Development Program of China

National Key Program for Infectious Disease of China

National Natural Science Foundation of China International Cooperation and Exchange Program

National Institutes of Health

Sanming Project of Medicine in Shenzhen

Canadian Institutes of Health Research

Shenzhen Science and Technology Research and Development Project

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2017.1412024

Reference8 articles.

1. The gold industry standard for risk and cost of drug and vaccine development revisited

2. New Vaccines against Epidemic Infectious Diseases

3. Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

4. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses

5. A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inequitable access to Ebola vaccines and the resurgence of Ebola in Africa: A state of arts review;Journal of Medical Virology;2023-08

2. Ganoderma lucidum: Unutilized natural medicine and promising future solution to emerging diseases in Africa;Frontiers in Pharmacology;2022-08-22

3. Middle East Respiratory Syndrome coronavirus vaccine development: updating clinical studies using platform technologies;Journal of Microbiology;2022-01-28

4. Techniques for Developing and Assessing Immune Responses Induced by Synthetic DNA Vaccines for Emerging Infectious Diseases;Vaccine Design;2021-12-17

5. A Proteome-Wide Immunoinformatics Tool to Accelerate T-Cell Epitope Discovery and Vaccine Design in the Context of Emerging Infectious Diseases: An Ethnicity-Oriented Approach;Frontiers in Immunology;2021-02-26